Sort   by:  
 Page size 
UnknownIncidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children.
Not available
S-EPMC3265045 | biostudies-literature
UnknownValidation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations.
Not available
S-EPMC6369893 | biostudies-literature
UnknownAnalysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.
Not available
S-EPMC9857265 | biostudies-literature
UnknownHigh-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness.
Not available
S-EPMC9621697 | biostudies-literature
UnknownAnakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness.
Not available
S-EPMC9673073 | biostudies-literature
UnknownSpinal cord lesions and disability in Hispanics with multiple sclerosis.
Not available
S-EPMC3816004 | biostudies-literature
UnknownMultiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.
Not available
S-EPMC10176621 | biostudies-literature
UnknownRituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden.
Not available
S-EPMC8637249 | biostudies-literature
UnknownThe impact of timing of initiating invasive mechanical ventilation in COVID-19-related respiratory failure.
Not available
S-EPMC10165890 | biostudies-literature
UnknownThe intensity of anticoagulant dosing in hospitalized patients with COVID-19: An observational, comparative effectiveness study.
Not available
S-EPMC9877905 | biostudies-literature
Sort   by:  
 Page size